WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017201071) COMBINATION THERAPY FOR MALE SEXUAL DYSFUNCTION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/201071    International Application No.:    PCT/US2017/032942
Publication Date: 23.11.2017 International Filing Date: 16.05.2017
IPC:
A61K 31/475 (2006.01), A61K 31/519 (2006.01), A61K 31/4985 (2006.01), A61P 15/00 (2006.01), A61K 31/505 (2006.01), A61K 31/495 (2006.01), A61K 31/343 (2006.01)
Applicants: FOSTER, Howell [US/US]; (US)
Inventors: FOSTER, Howell; (US)
Agent: ZAHNER, Joseph; The Law Office of Joseph Zahner 600 W. 50th Street Kansas City, Missouri 64112 (US)
Priority Data:
62/336,797 16.05.2016 US
Title (EN) COMBINATION THERAPY FOR MALE SEXUAL DYSFUNCTION
(FR) POLYTHÉRAPIE POUR UN DYSFONCTIONNEMENT SEXUEL CHEZ L'HOMME
Abstract: front page image
(EN)Pharmaceutical formulations containing a serotonin reuptake inhibitor and a smooth muscle relaxant are provided for the treatment of premature ejaculation and the increase in intravaginal ejaculatory latency time. Specific formulations contain tadalafil (1-30 mg per dose) or tamsulosin (0.05-2 mg) and escitalopram (1-30 mg) in daily dose and on-demand formulations.
(FR)L'invention concerne des formulations pharmaceutiques contenant un inhibiteur de recaptage de la sérotonine et un relaxant des muscles lisses, destinées au traitement de l'éjaculation précoce et à l'augmentation du temps de latence de l'éjaculation intravaginale. Des formulations spécifiques contiennent du tadalafil (1 à 30 mg par dose) ou de la tamsulosine (0,05 à 2 mg) et de l'escitalopram (1 à 30 mg) dans des formulations à dose quotidienne et à la demande.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)